Fraction of Cases of Acquired Immunodeficiency Syndrome Prevented by the Interactions of Identified Restriction Gene Variants

American Journal of Epidemiology

Volumn 159, Issue 3, 2004, Pages 232-241

  Silverberg, Michael J ^a   Smith, M W ^b   Chmiel, J S ^c   Detels, R ^d   Margolick, J B ^a   Rinaldo, C R ^e   O'Brien, S J ^f   Munoz A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SAIC FREDERICK INC   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Chemokines; Cytokines; Epidemiologic methods; HIV 1; HLA antigens; Receptors, chemokine

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 10; STROMAL CELL DERIVED FACTOR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONFIDENCE INTERVAL; COX PROPORTIONAL HAZARDS MODEL; FOLLOW UP; GENE ISOLATION; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PROMOTER REGION; REGRESSION ANALYSIS; RESTRICTION MAPPING; SEROCONVERSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; EPIDEMIOLOGIC METHODS; GENOTYPE; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MULTICENTER STUDIES; PROSPECTIVE STUDIES; UNITED STATES;

EID: 0942279637     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh036     Document Type: Article

References (32)

1. Muñoz A, Sabin CA, Phillips AN. The incubation period of AIDS. AIDS 1997;11(suppl A):S69-76.
2. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 1990;301:1183-8.
3. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992;5:490-6.
4. Buchbinder SP, Katz MH, Hessol NA, et al. Long-term HIV-1 infection without immunologic progression. AIDS 1994;8:1123-8.
5. Rowe WP, Humphrey JB, Lilly F. A major genetic locus affecting resistance to infection with murine leukemia viruses. 3. Assignment of the Fv-1 locus to linkage group 8 of the mouse. J Exp Med 1973;137:850-3.
6. O'Brien SJ, Roelke ME, Marker L, et al. Genetic basis for species vulnerability in the cheetah. Science 1985;227:1428-34.
7. Gardner MB, Kozak CA, O'Brien SJ. The Lake Casitas wild mouse: evolving genetic resistance to retroviral disease. Trends Genet 1991;7:22-7.
8. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
9. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
10. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
11. Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997;3:23-36.
12. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.
13. Martin MP, Dean M, Smith MW, et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998;282:1907-11.
14. McDermott DH, Zimmerman PA, Guignard F, et al. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 1998;352:866-70.
15. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998;279:389-93.
16. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-52.
17. Shin HD, Winkler C, Stephens JC, et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A 2000;97:14467-72.
18. Ioannidis JP, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-Δ32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 2001;135:782-95.
19. Kaslow RA, Ostrow DG, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-18.
20. 1993 revised classification system for HIV-1 infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
21. Kingsley LA, Zhou SY, Bacellar H, et al. Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989: a report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol 1991;134:331-9.
22. Detels R, Muñoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV-1 infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280:1497-503.
23. Muñoz A, Hoover DR. Use of cohort studies for evaluating AIDS therapies. In: Finkelstein DM, Schoenfeld DA, eds. AIDS clinical trials. New York, NY: John Wiley and Sons, Inc, 1995:423-46.
24. Cox DR, Oates D. Analysis of survival data. New York, NY: Chapman and Hall, Inc, 1984.
25. O'Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV-1 transmission and progression to AIDS. Immunol Rev 2000;177:99-111.
26. Ciampi A, Lawless JF, McKinney SM, et al. Regression and recursive partition strategies in the analysis of medical survival data. J Clin Epidemiol 1988;41:737-48.
27. LeBlanc M, Crowley J. Survival trees by goodness of split. J Am Stat Assoc 1993;88:457-67.
28. Breiman L, Friedman JH, Olshen RA, et al. Classification and regression trees. Monterey, CA: Wadsworth, Inc, 1984.
29. Segal MR. Regression trees for censored data. Biometrics 1988;44:35-47.
30. Zhang H, Singer B. Recursive partitioning in the health sciences. New York, NY: Springer Verlag, 1999.
31. O'Brien SJ, Nelson GW, Winkler CA, et al. Polygenic and multifactorial disease gene association in man: lessons from AIDS. Annu Rev Genet 2000;34:563-91.
32. Little RJ, Rubin DB. Statistical analysis with missing data. 1st ed. New York, NY: John Wiley and Sons, Inc, 1987.